Terms: = Ovarian cancer AND EPS15, AF-1P, 2060, ENSG00000085832, P42566, MLLT5, AF1P AND Treatment
8 results:
1. Chemoresistance in ovarian cancer: Prospects for New Drugs.
Tendulkar S; Dodamani S
Anticancer Agents Med Chem; 2021; 21(6):668-678. PubMed ID: 32900355
[TBL] [Abstract] [Full Text] [Related]
2. Comparative analysis of tumor spheroid generation techniques for differential in vitro drug toxicity.
Raghavan S; Mehta P; Horst EN; Ward MR; Rowley KR; Mehta G
Oncotarget; 2016 Mar; 7(13):16948-61. PubMed ID: 26918944
[TBL] [Abstract] [Full Text] [Related]
3. A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma.
Penson RT; Moore KM; Fleming GF; Braly P; Schimp V; Nguyen H; Matulonis UA; Banerjee S; Haluska P; Gore M; Bodurka DC; Hozak RR; Joshi A; Xu Y; Schwartz JD; McGuire WP
Gynecol Oncol; 2014 Sep; 134(3):478-85. PubMed ID: 25016924
[TBL] [Abstract] [Full Text] [Related]
4. A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer.
Xiao K; Luo J; Fowler WL; Li Y; Lee JS; Xing L; Cheng RH; Wang L; Lam KS
Biomaterials; 2009 Oct; 30(30):6006-16. PubMed ID: 19660809
[TBL] [Abstract] [Full Text] [Related]
5. [Preventive surgical prcedures for inherited risk of breast cancer].
Menke-Pluymers MB; Seynaeve C; van Geel AN; Klijn JG; Meijers-Heijboer EJ; Eggermont AM
Ned Tijdschr Geneeskd; 2005 Nov; 149(48):2663-7. PubMed ID: 16358615
[TBL] [Abstract] [Full Text] [Related]
6. DNA ploidy and S phase fraction of breast and ovarian tumor cells treated with a natural anthracycline analog (aloin).
Esmat AY; El-Gerzawy SM; Rafaat A
Cancer Biol Ther; 2005 Jan; 4(1):108-12. PubMed ID: 15662120
[TBL] [Abstract] [Full Text] [Related]
7. Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer.
Galper S; Gelman R; Recht A; Silver B; Kohli A; Wong JS; Van Buren T; Baldini EH; Harris JR
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):406-14. PubMed ID: 11872286
[TBL] [Abstract] [Full Text] [Related]
8. Meta-analysis of cisplatin, doxorubicin, and cyclophosphamide versus cisplatin and cyclophosphamide chemotherapy of ovarian carcinoma.
Fanning J; Bennett TZ; Hilgers RD
Obstet Gynecol; 1992 Dec; 80(6):954-60. PubMed ID: 1333066
[TBL] [Abstract] [Full Text] [Related]
